ORIA
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
ORIA
Delisted
ORIA was delisted on the 28th of April, 2023.
40 hedge funds and large institutions have $124M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
40
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.82M | |
| 2 | +$4.88M | |
| 3 | +$4.87M | |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$4.77M |
| 5 |
Millennium Management
New York
|
+$1.32M |
Top Sellers
| 1 | -$5.03M | |
| 2 | -$2.93M | |
| 3 | -$2.51M | |
| 4 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$937K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$880K |